Is CPPED1 p.Glu60Lys (c.178G>A) pathogenic?

CPPED1 p.Glu60Lys (c.178G>A) is classified Uncertain significance in CPPED1 (ClinVar, Single submitter, 1 submitter; last evaluated 2021-08-17). AlphaMissense: likely benign (0.167); Rare (popmax 0.105%, nfe).

How common is CPPED1 p.Glu60Lys (c.178G>A) in the general population?

CPPED1 p.Glu60Lys (c.178G>A) is rare (popmax 0.105%, nfe) (gnomAD).

What do computational predictors say about CPPED1 p.Glu60Lys (c.178G>A)?

AlphaMissense predicts likely benign (score 0.167) — an in-silico prediction, not a clinical call.

CPPED1 p.Glu60Lys

c.178G>A · rs201377568 · VCV2392807

Uncertain significance Single submitter

Classification

Uncertain significance

ClinVar

Review

Single submitter ★☆☆☆

ClinVar · 1 submitter

AlphaMissense

likely benign

0.167 · ACMG-weighted

gnomAD v4.1

Rare

rare (popmax 0.105%, nfe)

Missense predictors

0/2 damaging

AlphaMissense, SaProt · REVEL no call

Computational evidence

Protein change
AlphaMissense	0.167	likely benign
REVEL	0.322	indeterminate
SaProt	LLR -5.47	tolerated
⇒ AlphaMissense and SaProt both call this tolerated; REVEL makes no call.
Splicing
SpliceAI	—	not assessed · no allele here is in the release
Constraint at this position
Conservation	phyloP 4.8	GERP 1.6, phastCons 1
Regional constraint	o/e 1.21	unconstrained · MANE · 139 kb · p 1.8e-05 · regional, not allelic
Overall
CADD	21.2	PHRED · no single calibrated threshold — expert panels disagree

ClinVar classifies this uncertain; the computational predictors unanimously lean tolerated — a triage signal, not a reclassification

AlphaMissense carries the ACMG weight for missense; REVEL and SaProt are independent agreement signals.

Population frequency

gnomAD v4.1 · exomes + genomes

Grpmax group 0.105% European (non-Finnish) · 1,234/1,180,016 alleles

Filtering AF 0.0997% ClinGen BA1/BS1 input FAF95, joint · FAF99 0.0977%

Overall 0.08% 1,291/1,614,118 alleles · rare

Ancestry group	Frequency	1 in
European (non-Finnish)grpmax	0.105%	956
Remaining individualsnot grpmax-eligible	0.0544%	1,839
Finnishnot grpmax-eligible	0.0141%	7,114
African / African-American	0.0133%	7,504
Admixed American	0.00667%	15,001

Rarity supports pathogenicity (ACMG PM2); frequency above a disease-specific BA1/BS1 threshold argues against it. A variant frequent in one ancestry group can be near-absent in others, so a single global figure can mislead.

Variant & gene context

Gene: CPPED1
Protein: p.Glu60Lys
Coding: c.178G>A
MANE Select: NM_018340
dbSNP: rs201377568
Type: single nucleotide variant
Location: chr16:12781296 (GRCh38)
Gene constraint: LOEUF 1.288 · pLI <0.01 (gnomAD)
Structure: AlphaFold pLDDT 95.46
Residue 60: the 'catalytic' region

Full CPPED1 gene report on Sugi Atlas → Gene function, pathways, protein structure, interactions & more

Similar variants

CPPED1 p.Ala118Ser Uncertain significance ★ ⚠ same type
CPPED1 p.Ala192Val Uncertain significance ★ ⚠ same type
CPPED1 p.Ala200Thr Uncertain significance ★ ⚠ same type
CPPED1 p.Ala20Gly Uncertain significance ★ ⚠ same type
CPPED1 p.Ala20Pro Uncertain significance ★ ⚠ same type
CPPED1 p.Ala20Thr Uncertain significance ★ ⚠ same type
CPPED1 p.Ala238Thr Uncertain significance ★ ⚠ same type
CPPED1 p.Ala3Val Uncertain significance ★ ⚠ same type

Built on 18 open, versioned datasets — ClinVar, gnomAD, AlphaMissense, REVEL, ClinGen & more — plus Sugi Variant's own cross-source analysis. Source data 2026-01–2026-10, ClinVar 2026-10. Full sources & versions →

Cite Sugi Variant

Gür T. Sugi Variant: A Deterministic Per-Variant Germline Reference from a Knowledge Graph for Humans and AI Agents. 2026. doi:10.5281/zenodo.21509445. This variant: https://sugi.bio/variant/cpped1-p-glu60lys (accessed [today's date]).

Preprint & method: sugi.bio/variant/method Machine-readable: this page as Markdown